Jiao, Jingjing

Publishing since 1994 (Senior)

Has published 50 publications in 17 years

Number of publications published per year by Jiao, Jingjing. (Source : PubMed)

Distribution of publications types for Jiao, Jingjing. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Alani AW, Rao DA, Seidel R, Wang J, Jiao J, Kwon GS. The effect of novel surfactants and solutol(R) HS 15 on paclitaxel aqueous solubility and permeability across a Caco-2 monolayer.  J Pharm Sci  2010  
•  Xu Y, Wang JB, Xu J, Jiao J, Zhang YG, Ji SW, Zhao P, Guo HH, Li Y, Zhou CY. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis.]  Zhonghua Gan Zang Bing Za Zhi  2010;18;2  
•  Alaoui-Jamali MA, Bismar TA, Gupta A, Szarek WA, Su J, Song W, Xu Y, Xu B, Liu G, Vlahakis JZ, Roman G, Jiao J, Schipper HM. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer.  Cancer Res.  2009;69;20  
•  Jiao J, Qin Z, Li S, Liu H, Lu Z. Potential role of Notch1 signaling pathway in laryngeal squamous cell carcinoma cell line Hep-2 involving proliferation inhibition, cell cycle arrest, cell apoptosis, and cell migration.  Oncol. Rep.  2009;22;4  
•  Jiao J, Wang J, Sallberg M. Effects of HCV proteins in current HCV transgenic models.  Hepatol. Res.  2009  
•  Jiao J, Kim HY, Liu RR, Hogan CA, Sun K, Tam LM, Gunn TM. Transgenic analysis of the physiological functions of Mahogunin Ring Finger-1 isoforms.  Genesis  2009;47;8  
•  Lin Z, Murtaza I, Wang K, Jiao J, Gao J, Li PF. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy.  Proc. Natl. Acad. Sci. U.S.A.  2009;106;29  
•  Jiao J, Friedman SL, Aloman C. Hepatic fibrosis.  Curr. Opin. Gastroenterol.  2009;25;3  
•  Li S, Jiao J, Lu Z, Zhang M. An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells.  Oncol. Rep.  2009;21;5  
•  Ahlén G, Derk E, Weiland M, Jiao J, Rahbin N, Aleman S, Peterson DL, Pokrovskaja K, Grandér D, Frelin L, Sällberg M. Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.  Gut  2009;58;4  

[ See timeline ] [ See all publications ]